12.48
price down icon2.80%   -0.36
after-market After Hours: 12.30 -0.18 -1.44%
loading
Emergent Biosolutions Inc stock is traded at $12.48, with a volume of 2.36M. It is down -2.80% in the last 24 hours and up +41.50% over the past month. Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. The key revenue is generated through the commercial segment which consists of NARCAN and other commercial products.
See More
Previous Close:
$12.84
Open:
$12.77
24h Volume:
2.36M
Relative Volume:
1.95
Market Cap:
$665.82M
Revenue:
$1.02B
Net Income/Loss:
$-757.20M
P/E Ratio:
-0.8455
EPS:
-14.76
Net Cash Flow:
$-257.90M
1W Performance:
+28.13%
1M Performance:
+41.50%
6M Performance:
+133.71%
1Y Performance:
+37.75%
1-Day Range:
Value
$11.62
$13.00
1-Week Range:
Value
$9.21
$13.41
52-Week Range:
Value
$4.02
$13.41

Emergent Biosolutions Inc Stock (EBS) Company Profile

Name
Name
Emergent Biosolutions Inc
Name
Phone
240-631-3200
Name
Address
300 PROFESSIONAL DR, GAITHERSBURG, MD
Name
Employee
900
Name
Next Earnings Date
2025-03-03
Name
Latest SEC Filings
Name
EBS's Discussions on Twitter

Compare EBS with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Drug Manufacturers - Specialty & Generic icon
EBS
Emergent Biosolutions Inc
12.48 676.67M 1.02B -757.20M -257.90M -14.76
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
144.09 63.86B 9.39B 2.62B 2.22B 5.8121
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
13.44 41.80B 29.96B 957.25M 4.77B 0.2956
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
9.27 40.88B 14.26B 1.98B 2.47B 0.4327
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
20.48 22.98B 16.70B -157.13M 1.19B -0.1446
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
445.43 19.53B 3.08B 1.24B 1.07B 25.61

Emergent Biosolutions Inc Stock (EBS) Upgrades & Downgrades

Date Action Analyst Rating Change
Dec-30-24 Initiated H.C. Wainwright Buy
Aug-22-24 Initiated Rodman & Renshaw Buy
Mar-07-24 Upgrade The Benchmark Company Hold → Buy
Nov-20-23 Resumed JP Morgan Underweight
Aug-29-23 Downgrade The Benchmark Company Buy → Hold
Apr-10-23 Upgrade The Benchmark Company Hold → Buy
Mar-17-23 Downgrade JP Morgan Neutral → Underweight
Nov-10-22 Downgrade The Benchmark Company Buy → Hold
Apr-29-22 Downgrade Cantor Fitzgerald Overweight → Neutral
Jan-20-22 Upgrade The Benchmark Company Hold → Buy
Nov-08-21 Downgrade The Benchmark Company Buy → Hold
May-05-21 Downgrade Argus Buy → Hold
Apr-07-21 Initiated The Benchmark Company Buy
Feb-24-21 Upgrade Chardan Capital Markets Neutral → Buy
Feb-19-21 Downgrade Chardan Capital Markets Buy → Neutral
Jan-08-21 Downgrade Wells Fargo Overweight → Equal Weight
Sep-14-20 Resumed JP Morgan Neutral
Jul-31-20 Reiterated Chardan Capital Markets Buy
Sep-12-19 Initiated Guggenheim Buy
Sep-04-19 Upgrade Wells Fargo Market Perform → Outperform
Nov-02-18 Upgrade Goldman Neutral → Buy
Aug-03-18 Reiterated Chardan Capital Markets Buy
Jun-13-18 Initiated Argus Buy
Apr-25-18 Downgrade Wells Fargo Outperform → Market Perform
Jan-24-18 Initiated Goldman Neutral
Jan-16-18 Reiterated Chardan Capital Markets Buy
Jun-28-16 Reiterated Singular Research Buy
Apr-15-16 Initiated Chardan Capital Markets Buy
Mar-28-16 Initiated Singular Research Buy
Feb-19-16 Initiated Wells Fargo Outperform
May-15-14 Initiated Summer Street Research Buy
May-31-11 Reiterated WBB Securities Strong Buy
Jan-10-11 Reiterated Wedbush Outperform
Nov-05-10 Reiterated Wedbush Outperform
Aug-18-10 Upgrade WBB Securities Buy → Strong Buy
Aug-06-10 Reiterated Caris & Company Buy
View All

Emergent Biosolutions Inc Stock (EBS) Latest News

pulisher
12:00 PM

Biodefense Market to Attain USD 32.87 Billion by 2034, Driven by Biotech Advancements and Government Funding - GlobeNewswire Inc.

12:00 PM
pulisher
11:29 AM

Emergent Biosolutions (NYSE:EBS) Shares Gap Up After Strong Earnings - MarketBeat

11:29 AM
pulisher
09:15 AM

Emergent Biosolutions Inc. (EBS) Soars to 52-Week High, Time to Cash Out? - Yahoo Finance

09:15 AM
pulisher
07:04 AM

Emergent BioSolutions Raises Full-Year Revenue Guidance - MSN

07:04 AM
pulisher
06:57 AM

Reversal indicators forming on Emergent BioSolutions Inc. stock2025 Fundamental Recap & Free Fast Entry Momentum Trade Alerts - newser.com

06:57 AM
pulisher
06:27 AM

Will Emergent BioSolutions Inc. benefit from macro trendsWeekly Market Report & High Accuracy Investment Signals - newser.com

06:27 AM
pulisher
06:02 AM

Is Emergent BioSolutions Inc. stock dividend yield sustainableJuly 2025 PostEarnings & Risk Controlled Stock Pick Alerts - newser.com

06:02 AM
pulisher
05:24 AM

What sentiment indicators say about Emergent BioSolutions Inc. stock2025 Volume Leaders & Reliable Entry Point Alerts - newser.com

05:24 AM
pulisher
03:14 AM

symbol__ Stock Quote Price and Forecast - CNN

03:14 AM
pulisher
01:32 AM

How Emergent BioSolutions Inc. stock benefits from tech adoptionJuly 2025 Momentum & Verified Momentum Watchlists - newser.com

01:32 AM
pulisher
01:24 AM

Why Emergent BioSolutions Inc. (ER4) stock is trending on social media2025 Historical Comparison & Advanced Swing Trade Entry Plans - newser.com

01:24 AM
pulisher
01:06 AM

Emergent BioSolutions Reports Strong Q3 2025 Results - The Globe and Mail

01:06 AM
pulisher
01:05 AM

Why Emergent BioSolutions Inc. (ER4) stock is listed among top recommendations2025 Investor Takeaways & Expert Approved Trade Ideas - newser.com

01:05 AM
pulisher
12:50 PM

Will breakout in Emergent BioSolutions Inc. lead to full recovery2025 Market Trends & Low Drawdown Trading Techniques - newser.com

12:50 PM
pulisher
12:34 PM

Will Emergent BioSolutions Inc. stock return to pre crisis levelsPortfolio Update Report & Stepwise Trade Signal Guides - newser.com

12:34 PM
pulisher
12:22 PM

Why Emergent BioSolutions Inc. stock remains resilientJuly 2025 Highlights & AI Driven Price Predictions - newser.com

12:22 PM
pulisher
Oct 30, 2025

Emergent Biosolutions (NYSE:EBS) Issues Quarterly Earnings Results, Beats Expectations By $1.18 EPS - MarketBeat

Oct 30, 2025
pulisher
Oct 30, 2025

Emergent BioSolutions Inc (EBS) Q3 2025 Earnings Call Highlights: Surpassing Revenue ... By GuruFocus - Investing.com Canada

Oct 30, 2025
pulisher
Oct 30, 2025

Emergent BioSolutions (EBS) Earnings Transcript - The Globe and Mail

Oct 30, 2025
pulisher
Oct 30, 2025

Emergent BioSolutions Inc (EBS) Q3 2025 Earnings Call Highlights: Surpassing Revenue ... - Yahoo Finance

Oct 30, 2025
pulisher
Oct 30, 2025

Emergent BioSolutions raises 2025 guidance to $835M revenue and $210M EBITDA as international MCM sales surge - MSN

Oct 30, 2025
pulisher
Oct 30, 2025

Gaithersburg-based Emergent Biosolutions reports Q3 earnings - Maryland Daily Record

Oct 30, 2025
pulisher
Oct 30, 2025

Analyzing Emergent BioSolutions Inc. with multi timeframe chartsQuarterly Trade Summary & Fast Moving Stock Watchlists - newser.com

Oct 30, 2025
pulisher
Oct 30, 2025

Will Emergent BioSolutions Inc. stock sustain high P E ratiosJuly 2025 Gainers & Precise Buy Zone Identification - newser.com

Oct 30, 2025
pulisher
Oct 30, 2025

Why Emergent BioSolutions Inc. (ER4) stock remains top ratedMarket Growth Summary & Verified Entry Point Signals - newser.com

Oct 30, 2025
pulisher
Oct 30, 2025

Emergent Biosolutions: Q3 Earnings Snapshot - Stamford Advocate

Oct 30, 2025
pulisher
Oct 30, 2025

Understanding Emergent BioSolutions Inc.’s price movementWeekly Earnings Recap & Real-Time Chart Breakout Alerts - newser.com

Oct 30, 2025
pulisher
Oct 30, 2025

Why millennials buy Emergent BioSolutions Inc. (ER4) stockShort Setup & Real-Time Chart Breakout Alerts - newser.com

Oct 30, 2025
pulisher
Oct 29, 2025

Is Emergent BioSolutions Inc. a candidate for recovery playGlobal Markets & Community Trade Idea Sharing Platform - newser.com

Oct 29, 2025
pulisher
Oct 29, 2025

Emergent Biosolutions earnings beat by $1.01, revenue topped estimates - Investing.com Canada

Oct 29, 2025
pulisher
Oct 29, 2025

Emergent Biosolutions (EBS) Beats Q3 Earnings and Revenue Estimates - sharewise.com

Oct 29, 2025
pulisher
Oct 29, 2025

EBS Boosts Financial Outlook for Fiscal Year - GuruFocus

Oct 29, 2025
pulisher
Oct 29, 2025

Emergent BioSolutions Inc Bottom Line Drops In Q3 - Nasdaq

Oct 29, 2025
pulisher
Oct 29, 2025

Emergent BioSolutions Inc Reports Q3 2025 Earnings: EPS of $0.91 - GuruFocus

Oct 29, 2025
pulisher
Oct 29, 2025

Emergent BioSolutions Q3 revenue beats guidance, raises full-year outlook - TradingView

Oct 29, 2025
pulisher
Oct 29, 2025

Emergent BioSolutions Reports Third Quarter 2025 Financial Results - The Manila Times

Oct 29, 2025
pulisher
Oct 29, 2025

How Emergent BioSolutions Inc. (ER4) stock behaves in tightening cyclesJuly 2025 Catalysts & Community Trade Idea Sharing Platform - newser.com

Oct 29, 2025
pulisher
Oct 29, 2025

Investors in Emergent BioSolutions (NYSE:EBS) have unfortunately lost 90% over the last five years - Yahoo Finance

Oct 29, 2025
pulisher
Oct 29, 2025

Chart based exit strategy for Emergent BioSolutions Inc.Watch List & High Accuracy Investment Entry Signals - newser.com

Oct 29, 2025
pulisher
Oct 29, 2025

Why Emergent BioSolutions Inc. stock could rally in 20252025 Short Interest & Growth Oriented Trading Recommendations - newser.com

Oct 29, 2025

Emergent Biosolutions Inc Stock (EBS) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$45.46
price up icon 3.18%
$22.15
price down icon 1.86%
drug_manufacturers_specialty_generic RDY
$13.29
price down icon 1.19%
$10.36
price up icon 0.00%
$143.21
price up icon 3.75%
$445.43
price down icon 1.79%
Cap:     |  Volume (24h):